RGD-Las

General Information


DRACP ID  DRACP00407

Peptide Name   RGD-Las

Sequence  RGDLLRHVVKILSKYL

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Arg-Gly-Asp(RGD) tripeptide ana temporins

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SW1116 Colon adenocarcinoma Carcinoma 81.465 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
SMMC-7721 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 86.175 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 78.045 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
Hep-G2 Hepatoblastoma; Hepatoblastoma Blastoma 73.07 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
BGC-823 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 73.705 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
A549 Lung adenocarcinoma Carcinoma 52.50 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
HL-7702(L-02) Human papillomavirus-related endocervical adenocarcinoma Carcinoma 38.13 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
MEC Cholangiocarcinoma; Cholangiocarcinoma Carcinoma 29.33 Inhibition ratio at 50 µg/ml MTT assay 24 h 1

Hemolytic Activity  Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml

Normal (non-cancerous) Cytotoxicity  Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml

Target  Not available

Affinity  Not available

Mechanism  A membrane-disturbing action seems to be the major mechanism for cell death

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00407

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C88H152N26O21

Absent amino acids  ACEFMNPQTW

Common amino acids  L

Mass  217808

Pl  10.89

Basic residues  5

Acidic residues  1

Hydrophobic residues  7

Net charge  4

Boman Index  -2424

Hydrophobicity  13.13

Aliphatic Index  158.13

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  99.33

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22641352

Title  Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain

Doi 10.1002/psc.2420

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.